One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put AMAG Pharmaceuticals, Inc. AMAG stock into this …
AMAG Pharmaceuticals
AMAG) with a price target of $25.00. There are 1 sell rating, 8 hold ratings, 4 buy ratings on the stock. The current consensus rating on AMAG Pharmaceuticals (NASDAQ:AMAG) is Hold (Score: 2.23) with a consensus target …
AMAG Pharmaceuticals
Finally, AMAG's stock was downgraded on Monday by both analysts at both Zachs and Raymond James. Given the barrage of news, it is hard …
AMAG Pharmaceuticals
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)‘s stock had its “underperform” rating reissued by Raymond James Financial, Inc. in a report released on Monday. Other equities research analysts have also issued …
BNS9d
AMAG Pharmaceuticals
Gevo Inc. (GEVO) had a gap down of (0.58) pts or -14.32 pct below its …
previous close
Fortunately, AMAG issued stock at these elevated levels, bolstering the balance sheet before shares retreated and fell back to levels around the $20 mark in the period 2011-2014. Shares promptly doubled from $20 to $40 …
AMAG
Leerink Swann currently has a “Market Perform” rating and a $25.00 target price on the stock. Leerink Swann also issued estimates for AMAG Pharmaceuticals’ Q3 2017 earnings at $0.43 EPS and Q4 2017 earnings at $0.57 …
AMAG Pharmaceuticals